Literature DB >> 2341409

A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat.

W G Yarbrough1, V E Quarmby, J A Simental, D R Joseph, M Sar, D B Lubahn, K L Olsen, F S French, E M Wilson.   

Abstract

The complete form of androgen insensitivity is an inherited X-linked syndrome in which genetic males fail to undergo masculinization in utero due to defective functioning of the androgen receptor (AR). The molecular basis of androgen insensitivity was investigated in the testicular feminized (Tfm) rat with this syndrome. AR mRNA size and amount, as well as nuclear AR protein revealed by immunocytochemistry, suggested normal expression of the AR gene in the Tfm rat. Sequence analysis of the AR coding region from Tfm and wild-type littermate male rats revealed a single transition mutation, guanine to adenine, within exon E, changing arginine 734 to glutamine within the steroid-binding domain of the AR. This arginine is highly conserved among the family of nuclear receptors and may be part of a phosphorylation recognition site. A recreated mutant AR (Arg734----Gln) expressed in COS cells had only 10-15% of the androgen-binding capacity of wild-type AR; the reduced androgen-binding capacity was similar to that of AR in tissue extracts of the Tfm rat. Stimulation of transcriptional activity by the recreated mutant AR was reduced relative to wild-type AR in cotransfection assays in CV1 cells using as reporter plasmid the mouse mammary tumor virus promoter linked to the chloramphenicol acetyltransferase gene. Thus, arginine 734 appears essential for normal AR function both in androgen binding and transcriptional activation. Absence of these functions results in androgen insensitivity and lack of male sexual development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341409

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Of mice and rats: key species variations in the sexual differentiation of brain and behavior.

Authors:  P J Bonthuis; K H Cox; B T Searcy; P Kumar; S Tobet; E F Rissman
Journal:  Front Neuroendocrinol       Date:  2010-05-10       Impact factor: 8.606

2.  Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene.

Authors:  M J McPhaul; M Marcelli; S Zoppi; C M Wilson; J E Griffin; J D Wilson
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 3.  Molecular basis of androgen resistance.

Authors:  M Marcelli; W D Tilley; S Zoppi; J E Griffin; J D Wilson; M J McPhaul
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

4.  Effects of androgens and estradiol on spine synapse formation in the prefrontal cortex of normal and testicular feminization mutant male rats.

Authors:  Tibor Hajszan; Neil J MacLusky; Jamie A Johansen; Cynthia L Jordan; Csaba Leranth
Journal:  Endocrinology       Date:  2007-02-22       Impact factor: 4.736

Review 5.  Role of androgens and the androgen receptor in remodeling of spine synapses in limbic brain areas.

Authors:  Tibor Hajszan; Neil J MacLusky; Csaba Leranth
Journal:  Horm Behav       Date:  2007-12-31       Impact factor: 3.587

6.  Zinc fingers, zinc clusters, and zinc twists in DNA-binding protein domains.

Authors:  B L Vallee; J E Coleman; D S Auld
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

7.  Sexual differentiation of the nervous system: where the action is.

Authors:  M L Seney; N G Forger
Journal:  Endocrinology       Date:  2009-07       Impact factor: 4.736

Review 8.  The role of androgen receptors in the masculinization of brain and behavior: what we've learned from the testicular feminization mutation.

Authors:  Damian G Zuloaga; David A Puts; Cynthia L Jordan; S Marc Breedlove
Journal:  Horm Behav       Date:  2008-02-15       Impact factor: 3.587

9.  Sex differences and laterality in astrocyte number and complexity in the adult rat medial amygdala.

Authors:  Ryan T Johnson; S Marc Breedlove; Cynthia L Jordan
Journal:  J Comp Neurol       Date:  2008-12-10       Impact factor: 3.215

10.  Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer.

Authors:  Puranik Purushottamachar; Abhijit M Godbole; Lalji K Gediya; Marlena S Martin; Tadas S Vasaitis; Andrew K Kwegyir-Afful; Senthilmurugan Ramalingam; Zeynep Ates-Alagoz; Vincent C O Njar
Journal:  J Med Chem       Date:  2013-06-07       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.